Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
Mesenchymal stem cells (MSCs) loaded with oncolytic viruses are presently being investigated as a new modality of advanced/metastatic tumors treatment and enhancement of virotherapy. MSCs can, however, either promote or suppress tumor growth. To address the critical question of how MSCs loaded with...
Автори: | Mahasa, K, De Pillis, L, Ouifki, R, Eladdadi, A, Maini, P, Yoon, A, Yun, C |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Springer Nature
2020
|
Схожі ресурси
Схожі ресурси
-
Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach.
за авторством: Khaphetsi Joseph Mahasa, та інші
Опубліковано: (2017-01-01) -
A combination therapy of oncolytic viruses and chimeric antigen receptor T cells: a mathematical model proof-of-concept
за авторством: Khaphetsi Joseph Mahasa, та інші
Опубліковано: (2022-03-01) -
Enhancement of chemotherapy using oncolytic virotherapy: Mathematical and optimal control analysis
за авторством: Joseph Malinzi, та інші
Опубліковано: (2018-11-01) -
Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
за авторством: Alberto Reale, та інші
Опубліковано: (2021-12-01) -
Oncolytic virotherapy
за авторством: Daniel Cervantes-García;, та інші
Опубліковано: (2008-01-01)